NJ-based Johnson & Johnson says COVID-19 vaccine is safe, showing promising immune response
Johnson & Johnson says its COVID-19 vaccine is safe and
showing a promising immune response.
The company has reported few
side effects in early trials, things such as headache, muscle aches, and
Data shows most volunteers
developed antibodies after 28 days.
Johnson & Johnson's
vaccine requires only one dose, while Pfizer's and Moderna's require two.